Skip to main content

Table 2 Morphological characteristics of Swi/Snf-deficient ECAs

From: Clinicopathological characterization of Switch/Sucrose-non-fermentable (Swi/Snf) complex (ARID1A, SMARCA2, SMARCA4)-deficient endocervical adenocarcinoma

Parameters

Total (n = 604)

Swi/Snf-intact (n = 568)

Swi/Snf-deficient (n = 36)

P

Medullary, n (%)

   

< 0.001

Absent

574(95.0)

555(97.7)

19(52.8)

 

Present

30(5.0)

13(2.3)

17(47.2)

 

Signet ring cell (≥ 5%), n (%)

   

1

Absent

587(97.2)

552(97.2)

35(97.2)

 

Present

17(2.8)

16(2.8)

1(2.8)

 

Micropapillary (≥ 10%), n (%)

   

0.861

Absent

562(93.0)

507(89.3)

33(91.7)

 

Present

42(7.0)

61(10.7)

3(8.3)

 

Tumor heterogeneity, n (%)

   

< 0.001

Absent

480(79.5)

461(81.2)

19(52.8)

 

Present

124(20.5)

107(18.8)

17(47.2)

 

Differentiation, n (%)

   

0.004

Well

34(5.6)

33(5.8)

1(2.8)

 

Moderate

331(54.8)

320(56.3)

11(30.5)

 

Poor

239(39.6)

215(37.9)

24(66.7)

 

Nuclear grade, n (%)

   

0.001

1

51(8.4)

51(9.0)

0(0)

 

2

352(58.3)

338(59.5)

14(38.9)

 

3

201(33.3)

179(31.5)

22(61.1)

 

Mitosis (/10HPF)

   

0.217

Median (range)

20.00(0-240)

21.00(0-240)

16.00(0–90)

 

Necrosis, n (%)

   

0.001

Absent

417(69.0)

401(70.6)

16(44.4)

 

Present

187(31.0)

167(29.4)

20(55.6)

 

Host inflammatory response

    

sTILs, (%)

   

< 0.001

Median(range)

15.00(1–90)

10(1–90)

60.00(1–90)

 

Peritumoral lymphocytes, n (%)

   

0.001

Absent

367(60.8)

358(63.0)

9(25.0)

 

Present

237(39.2)

210(37.0)

27(75.0)

 

TLS, n (%)

   

< 0.001

Absent

515(85.3)

494(87.0)

21(58.3)

 

Present

89(14.7)

74(13.0)

15(41.7)

 

Neutrophilic infiltration, n (%)

   

0.052

Absent

519(85.9)

492(86.6)

27(75)

 

Present

85(14.1)

76(13.4)

9(25)

 
  1. sTILs, stomal tumor-infiltrating lymphocytes; TLS, tertiary lymphoid structures. All P-values were two-sided, and differences were considered statistically significant when P < 0.05